Literature DB >> 8314219

Verrucous naevoid and keratotic malignant melanoma: a clinico-pathological study of 20 cases.

K Blessing1, A T Evans, A al-Nafussi.   

Abstract

Verrucous naevoid malignant melanoma is a recently described variant of malignant melanoma that may be confused both clinically and histologically with benign lesions. This study reports the clinical and pathological features of 20 such cases. These constituted 3.2% of all melanomas diagnosed in the Department of Pathology, Aberdeen University, in the period 1970-1991. They occurred more often on the back and limbs of male patients with a mean age of 57 years. Clinical diagnosis of benign lesions (warty naevi, papillomas, seborrhoeic keratosis and cysts) were made in over 50% of the cases. Eight patients had metastases, seven of whom died of their disease. Microscopically, these lesions exhibited a spectrum of naevoid features such as symmetry, exophytic and papilliferous growth pattern, hyperkeratosis and pseudo-epitheliomatous hyperplasia. The majority, however, showed lateral intra-epidermal spread and were composed of large epithelioid cells exhibiting various degrees of cellular pleomorphism. Histological classification was difficult, as more than 50% of the cases were initially labelled unclassifiable. The marked papilliferous architecture of these lesions made assessment of Breslow depth and Clark levels difficult. Initially, 10% of the cases were histologically diagnosed as benign. It is therefore important for surgical pathologists to recognize this unusual variant of malignant melanoma, as it may be confused both clinically and pathologically with benign lesions.

Entities:  

Mesh:

Year:  1993        PMID: 8314219     DOI: 10.1111/j.1365-2559.1993.tb00494.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  8 in total

Review 1.  [Histological spectrum of malignant melanoma].

Authors:  T Brenn
Journal:  Pathologe       Date:  2015-02       Impact factor: 1.011

2.  Morphological and molecular characteristics of nested melanoma of the elderly (evolved lentiginous melanoma).

Authors:  Ilaria Pennacchia; Simone Garcovich; Rita Gasbarra; Alvaro Leone; Vincenzo Arena; Guido Massi
Journal:  Virchows Arch       Date:  2012-08-15       Impact factor: 4.064

Review 3.  Problematic pigmented lesions: approach to diagnosis.

Authors:  S L Edwards; K Blessing
Journal:  J Clin Pathol       Date:  2000-06       Impact factor: 3.411

4.  Small cell malignant melanoma: a variant of naevoid melanoma. Clinicopathological features and histological differential diagnosis.

Authors:  K Blessing; J J Grant; D S Sanders; M M Kennedy; A Husain; P Coburn
Journal:  J Clin Pathol       Date:  2000-08       Impact factor: 3.411

5.  Dermoscopic Clues for Diagnosing Melanomas That Resemble Seborrheic Keratosis.

Authors:  Cristina Carrera; Sonia Segura; Paula Aguilera; Massimiliano Scalvenzi; Caterina Longo; Alicia Barreiro; Paolo Broganelli; Stefano Cavicchini; Alex Llambrich; Pedro Zaballos; Luc Thomas; Josep Malvehy; Susana Puig; Iris Zalaudek
Journal:  JAMA Dermatol       Date:  2017-06-01       Impact factor: 10.282

6.  Verrucous-Keratotic Malignant Melanoma (VKMM).

Authors:  Nikolay Damianov; Michael Tronnier; Nely Koleva; Uwe Wollina; Serena Gianfaldoni; Torello Lotti; Jacopo Lotti; Katlein França; Atanas Batashki; Hristo Mangarov; Georgi Tchernev
Journal:  Open Access Maced J Med Sci       Date:  2017-07-24

7.  Malignant melanoma with a seborrheic keratosis-like clinical presentation.

Authors:  Kunitaka Haruna; Yasushi Suga; Yuki Mizuno; Shigaku Ikeda
Journal:  Indian J Dermatol       Date:  2009       Impact factor: 1.494

8.  Optimization of an automated tumor-infiltrating lymphocyte algorithm for improved prognostication in primary melanoma.

Authors:  Margaret Chou; Irineu Illa-Bochaca; Ben Minxi; Farbod Darvishian; Paul Johannet; Una Moran; Richard L Shapiro; Russell S Berman; Iman Osman; George Jour; Hua Zhong
Journal:  Mod Pathol       Date:  2020-10-01       Impact factor: 7.842

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.